Literature DB >> 9843166

Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.

P Y Scarabin1, M F Aillaud, P Amouyel, A Evans, G Luc, J Ferrières, D Arveiler, I Juhan-Vague.   

Abstract

The contribution of coagulation factors and fibrinolytic variables to the development of ischaemic arterial disease is still not clearly established. The PRIME study is a prospective cohort study of myocardial infarction in men aged 50-59 years and recruited from three MONICA field centers in France (Lille, Strasbourg and Toulouse) and the center in Northern Ireland (Belfast). Baseline examination included measurement of plasma fibrinogen, factor VII, and PAI-1 activity in over 10,500 participants. We investigated the associations of these haemostatic variables with cardiovascular risk factors, prevalent atherosclerotic disease and geographical area. Fibrinogen level increased with age, smoking, waist-to-hip ratio, LDL-cholesterol, and it decreased with educational level, leisure physical activity, alcohol intake and HDL-cholesterol. Factor VII activity increased with body mass index, waist-to-hip ratio, triglycerides. HDL- and LDL-cholesterol. PAI-1 activity increased with body mass index, waist-to-hip ratio, triglycerides, alcohol intake, smoking, and decreased with leisure physical activity. PAI-1 level was higher in diabetic subjects than in subjects without diabetes. Cardiovascular risk factors explained 8%, 9%, and 26% of the total variance in fibrinogen, factor VII, and PAI-1, respectively. Compared with participants without prevalent cardiovascular disease, those with previous myocardial infarction (n = 280), angina pectoris (n = 230), or peripheral vascular disease (n = 19) had significantly higher levels of fibrinogen. but those with stroke (n = 67) had not. PAI-1 activity showed a similar pattern of association. The odds ratio for cardiovascular disease associated with a rise of a one standard deviation in fibrinogen and PAI-1 was 1.31 (95% confidence interval: 1.20 to 1.42, p <0.001) and 1.38 (95% confidence interval: 1.27 to 1.49, p<0.001), respectively. After adjustment for cardiovascular risk factors, these associations were attenuated but remained highly significant. There was no significant association between factor VII activity and prevalent cardiovascular disease. Fibrinogen level and, to a lesser extent, factor VII and PAI-1 activity were higher in Northern Ireland than France after adjustment for the main cardiovascular risk factors. These geographical variations are consistent with the 2 to 3-fold higher incidence of myocardial infarction in Northern Ireland than France. Our results provide further epidemiological evidence for a possible role of fibrinogen and PAI-1 in the pathogenesis of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843166

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  22 in total

Review 1.  Inflammation, coagulation, and the pathway to frailty.

Authors:  Bindu Kanapuru; William B Ershler
Journal:  Am J Med       Date:  2009-07       Impact factor: 4.965

2.  Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?

Authors:  Nabil M Al Lawati; Najib T Ayas
Journal:  Lung       Date:  2008-04-22       Impact factor: 2.584

3.  Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells.

Authors:  Yoshiyuki Rikitake; James K Liao
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

4.  Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles.

Authors:  Min Yu; Yiqun Mo; Rong Wan; Sufan Chien; Xing Zhang; Qunwei Zhang
Journal:  Toxicol Lett       Date:  2010-02-18       Impact factor: 4.372

Review 5.  Fibrinolytic function and coronary risk.

Authors:  I Juhan-Vague; P Morange; M Christine Alessi
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 6.  Fibrinogen and coronary risk.

Authors:  W Koenig
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 7.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

8.  Visceral obesity and hemostatic profile in patients with type 2 diabetes: the effect of gender and metabolic compensation.

Authors:  Elzbieta Kozek; Barbara Katra; Maciej Malecki; Jacek Sieradzki
Journal:  Rev Diabet Stud       Date:  2004-11-10

9.  Circadian variability of fibrinolytic markers and endothelial function in patients with obstructive sleep apnea.

Authors:  Kanika Bagai; James A S Muldowney; Yanna Song; Lily Wang; Jayant Bagai; Kay J Artibee; Douglas E Vaughan; Beth A Malow
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

Review 10.  Overview of hemostatic factors involved in atherosclerotic cardiovascular disease.

Authors:  William B Kannel
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.